Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2024

Investments, Debt and Equity Securities [Abstract]

Schedule of Available-for-Sale Marketable Securities

The following is a summary of available-for-sale financial instruments, as of March 31, 2024 and December 31, 2023, respectively (in thousands):

	March 31, 2024
	Amortized Cost		Unrealized Gain		Unrealized Losses		Fair Value
Marketable securities:
Corporate securities (1)	$	110,948	$	1	$	(681)	$	110,268
U.S. treasury and agency securities	21,442		3		(82)		21,363
Total Marketable securities	$	132,390	$	4	$	(763)	$	131,631
(1)Comprised primarily of corporate bonds

	December 31, 2023
	Amortized Cost		Unrealized Gain		Unrealized Losses		Fair Value
Cash equivalents:
Corporate securities (1)	$	1,213	$	—	$	(1)	$	1,212
Total cash equivalents	1,213		—		(1)		1,212
Marketable securities:
Corporate securities (1)	$	199,084	$	115	$	(819)	$	198,380
U.S. treasury and agency securities	30,404		25		(48)		30,381
Total Marketable securities	$	229,488	$	140	$	(867)	$	228,761
(1)Comprised primarily of corporate bonds and commercial paper

Schedule of Fair Values of Available-for-Sale Financial Instruments

As of March 31, 2024, the fair values of available-for-sale financial instruments, by remaining contractual maturity, were as follows (in thousands):

Due within one year	$	94,440
Due in one to five years	37,191
Total	$	131,631